Nonalcoholic Steatohepatitis Active Not Recruiting Phase 2 Trials for Pegbelfermin (DB15365)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03486899A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver FibrosisTreatment
NCT03486912A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver CirrhosisTreatment